SEC 13F Intelligence

Managers / Q1 2024 · view latest →

PLATINUM INVESTMENT MANAGEMENT LTD

CIK 0001256071 · C/O PLATINUM ASSET MANAGEMENT, LEVEL 8, 7 MACQUARIE PLACE, SYDNEY AUSTRALIA 2000, C3, 00000 · 61292557533

Reported Value
$2.5B
Q1 2024
Positions
139
Filings on Record
30
2019–present window
Filed
May 13, 2024
original filing

Summary

Platinum Investment Management Ltd reported $2.5B in U.S.-listed holdings across 139 positions for Q1 2024.

Its largest position, ZTO, represents 14.7% of the portfolio.

Compared with Q4 2023, the fund opened 15 new positions and exited 18.

Portfolio Metrics

Turnover
+16.4%
vs prior filed quarter
Top-10 Concentration
+64.8%
share of reported value
Largest Position
+14.7%
Zto Express Cayman
New / Exited
15 / 18
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $3.0BQ4 ’18Q1 ’19: $4.2BQ2 ’19: $4.3BQ3 ’19: $4.5BQ4 ’19: $5.0BQ4 ’19Q1 ’20: $4.0BQ2 ’20: $4.4BQ3 ’20: $4.0BQ4 ’20: $4.4BQ4 ’20Q1 ’21: $4.5BQ2 ’21: $4.3BQ3 ’21: $3.6BQ4 ’21: $3.6BQ4 ’21Q1 ’22: $3.3BQ2 ’22: $2.6BQ3 ’22: $2.4BQ4 ’22: $2.6BQ4 ’22Q1 ’23: $2.9BQ2 ’23: $2.9BQ3 ’23: $2.6BQ4 ’23: $2.5BQ4 ’23Q1 ’24: $2.5BQ2 ’24: $2.5BQ3 ’24: $2.2BQ4 ’24: $1.7BQ4 ’24Q1 ’25: $1.7BQ2 ’25: $1.5BQ3 ’25: $1.5BQ4 ’25: $433MQ4 ’25Q1 ’26: $397Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 61.8%ADR: 31.5%Other: 6.7%
  • Common Stock · 61.8% · $1.5B
  • ADR · 31.5% · $781M
  • Other · 6.7% · $167M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
CSGPCOSTAR GROUP INCNEW+50.0K50.0K+$5M$5M
ZTSZOETIS INCNEW+20.0K20.0K+$3M$3M
LULULULULEMON ATHLETICA INCNEW+7.0K7.0K+$3M$3M
ADSKAUTODESK INCNEW+7.8K7.8K+$2M$2M
QTTBQ32 BIO INCNEW+110.0K110.0K+$2M$2M
TECHBIO-TECHNE CORPNEW+22.8K22.8K+$2M$2M
ANABANAPTYSBIO INCNEW+66.2K66.2K+$1M$1M
FDMT4D MOLECULAR THERAPEUTICS INNEW+40.8K40.8K+$1M$1M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2024

49 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1ZTOZTO EXPRESS CAYMAN INChistory →SPONSORED ADS A14.71%$365M17.43M
2MUMICRON TECHNOLOGY INChistory →COM7.30%$181M1.54M
3ICEINTERCONTINENTAL EXCHANGE INhistory →COM6.61%$164M1.19M
4TRUTRANSUNIONhistory →COM6.49%$161M2.02M
5AVGOBROADCOM INChistory →COM5.62%$139M105.1K
6CLVTRIP COM GROUP LTDhistory →ADS5.58%$138M3.15M
7MCHPMICROCHIP TECHNOLOGY INC.history →COM5.56%$138M1.54M
8CCOCAMECO CORPhistory →COM5.40%$134M3.09M
9SLBSCHLUMBERGER LTDhistory →COM STK4.25%$105M1.92M
10METAMETA PLATFORMS INChistory →CL A3.32%$82M169.8K
11GOOGALPHABET INCCAP STK CL C · CAP STK CL A3.30%$82M538.8K
12VALARIS LTDCL A2.99%$74M986.8K
13BAXBAXTER INTL INChistory →COM2.81%$70M1.63M
14PDDPDD HOLDINGS INChistory →SPONSORED ADS2.61%$65M557.8K
15BABAALIBABA GROUP HLDG LTDhistory →SPONSORED ADS2.17%$54M745.0K
16PBRPETROLEO BRASILEIRO SA PETROhistory →SPONSORED ADR2.00%$50M3.25M
17MBLYMOBILEYE GLOBAL INChistory →COMMON CLASS A1.91%$47M1.47M
18BALLBALL CORPhistory →COM1.52%$38M558.3K
19SCORPIO TANKERS INCSHS1.30%$32M449.5K
20NOAHNOAH HLDGS LTDhistory →SPON ADS1.02%$25M2.21M
21METALS ACQUISITION LIMITEDORD SHS0.98%$24M1.90M
22EXAIEUREXSCIENTIA PLChistory →ADS0.91%$23M3.95M
23RXRXRECURSION PHARMACEUTICALS INhistory →CL A0.72%$18M1.80M
24JDJD.COM INChistory →SPON ADR CL A0.60%$15M542.5K
25DDLDINGDONG CAYMAN LTDhistory →ADS0.46%$11M9.32M
26HTHTH WORLD GROUP LTDhistory →SPONSORED ADS0.45%$11M288.9K
27APGEAPOGEE THERAPEUTICS INChistory →COM0.45%$11M167.9K
28VVISA INCCOM CL A0.39%$10M34.5K
29ADBEADOBE INCCOM0.36%$9M17.8K
30BCYCBICYCLE THERAPEUTICS PLCSPONSORED ADS0.33%$8M333.0K
31AMZNAMAZON COM INCCOM0.32%$8M43.3K
32IDYAIDEAYA BIOSCIENCES INCCOM0.29%$7M162.6K
33ROIVANT SCIENCES LTDSHS0.28%$7M669.0K
34VERAVERA THERAPEUTICS INCCL A0.27%$7M153.9K
35JNJJOHNSON & JOHNSONCOM0.25%$6M39.8K
36IMVTIMMUNOVANT INCCOM0.25%$6M190.7K
37GOSSGOSSAMER BIO INCCOM0.22%$6M4.69M
38260CENTESSA PHARMACEUTICALS PLCSPONSORED ADS0.22%$5M485.2K
39QTRXQUANTERIX CORPCOM0.21%$5M217.4K
40INBXUSDINHIBRX INCCOM0.21%$5M146.0K
41CSGPCOSTAR GROUP INCCOM0.19%$5M50.0K
42MERUS N VCOM0.18%$4M99.5K
43ABSIABSCI CORPORATIONCOM0.18%$4M776.6K
44ZYMEZYMEWORKS INCCOM0.18%$4M418.4K
45BKNGBOOKING HOLDINGS INCCOM0.17%$4M1.2K
46ESPRESPERION THERAPEUTICS INC NECOM0.17%$4M1.60M
47NFLXNETFLIX INCCOM0.16%$4M6.6K
48RCUSARCUS BIOSCIENCES INCCOM0.16%$4M204.4K
49BNTXBIONTECH SESPONSORED ADS0.16%$4M41.8K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$397M89May 14, 202613F-HRchanges · EDGAR ↗
Q4 2025$433M124Feb 13, 202613F-HRchanges · EDGAR ↗
Q3 2025$1.5B120Nov 13, 202513F-HRchanges · EDGAR ↗
Q2 2025$1.5B115Jul 21, 202513F-HRchanges · EDGAR ↗
Q1 2025$1.7B115May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$1.7B115Feb 11, 202513F-HRchanges · EDGAR ↗
Q3 2024$2.2B122Nov 8, 202413F-HRchanges · EDGAR ↗
Q2 2024$2.5B134Aug 13, 202413F-HRchanges · EDGAR ↗
Q1 2024$2.5B139May 13, 202413F-HRchanges · EDGAR ↗
Q4 2023$2.5B142Feb 13, 202413F-HRchanges · EDGAR ↗
Q3 2023$2.6B144Nov 3, 202313F-HRchanges · EDGAR ↗
Q2 2023$2.9B143Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$2.9B146May 12, 202313F-HRchanges · EDGAR ↗
Q4 2022$2.6B132Feb 13, 202313F-HRchanges · EDGAR ↗
Q3 2022$2.4B131Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$2.6B130Aug 11, 202213F-HRchanges · EDGAR ↗
Q1 2022$3.3B135May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$3.6B144Feb 11, 202213F-HRchanges · EDGAR ↗
Q3 2021$3.6B146Nov 9, 202113F-HRchanges · EDGAR ↗
Q2 2021$4.3B145Aug 11, 202113F-HRchanges · EDGAR ↗
Q1 2021$4.5B142May 13, 202113F-HRchanges · EDGAR ↗
Q4 2020$4.4B146Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$4.0B147Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$4.4B124Aug 6, 202013F-HRchanges · EDGAR ↗
Q1 2020$4.0B117May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$5.0B98Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$4.5B99Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$4.3B97Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$4.2B100May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$3.0B91Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.